Continuous glucose monitors (CGMs) are wearable technologies that track blood sugar in real time and help patients with type 2 diabetes improve blood sugar control. In 2024, the U.S. Food and Drug Administration approved over-the-counter CGMs for individuals with and without diabetes, but there is limited understanding of how to interpret CGM metrics in individuals who do not have diabetes.
This article was originally published on MedicalXpress.com